Denali Therapeutics Inc. (DNLI)

Denali Therapeutics Employees

Denali Therapeutics had 507 employees as of March 31, 2026. The number of employees increased by 64 or 14.45% compared to the same quarter last year.

• Employees: 507
• Change: 64
• Growth: 14.45%
• Revenue / Employee: n/a
• Profits / Employee: -$1,002,006
• Market Cap: 3.12B

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Mar 31, 2026	507	64	14.45%
Dec 31, 2025	503	81	19.19%
Sep 30, 2025	517	127	32.56%
Jun 30, 2025	486	122	33.52%
Mar 31, 2025	443	68	18.13%
Dec 31, 2024	422	-23	-5.17%
Sep 30, 2024	390	-57	-12.75%
Jun 30, 2024	364	-74	-16.89%
Mar 31, 2024	375	-55	-12.79%
Dec 31, 2023	445	18	4.22%
Sep 30, 2023	447	34	8.23%
Jun 30, 2023	438	43	10.89%
Mar 31, 2023	430	50	13.16%
Dec 31, 2022	427	47	12.37%
Sep 30, 2022	413	53	14.72%
Jun 30, 2022	395	61	18.26%
Mar 31, 2022	380	69	22.19%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Employee data is provided by S&P Global Market Intelligence and updates every three months after the filing of each quarterly report.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error